Detection and quantification of mutations in the plasma of patients with colorectal tumors
Open accessThe DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Abstract
The early detection of cancers through analysis of circulating DNA could have a substantial impact on morbidity and mortality. To achieve this goal, it is essential to determine the number of mutant molecules present in the circulation of cancer patients and to develop methods that are sufficiently sensitive to detect these mutations. Using a modified version of a recently developed assay for this purpose, we found that patients with advanced colorectal cancers consistently contained mutant adenomatous polyposis coli ( APC ) DNA molecules in their plasma. The median number of APC DNA fragments in such patients was 47,800 per ml of plasma, of which 8% were mutant. Mutant APC molecules were also detected in >60% of patients with early, presumably curable colorectal cancers, at levels ranging from 0.01% to 1.7% of the total APC molecules. These results have implications for the mechanisms through which tumor DNA is released into the circulation and for diagnostic tests based on this phenomenon.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This is a crucial consideration when considering cfDNA as a template as its concentration can range considerably; from 2 to 30 ng/ml plasma in healthy individuals to 180–600 ng/ml plasma both during pregnancy and in cancer patients (13,16,18,22–24).”
From Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation (2012) · cites this paper as [24]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Self-citationCancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
Self-citationJahr, S., Hentze, H., Englisch, S., Hardt, D., Fackelmayer, F. O., Hesch, R. D., & Knippers, R. (2001) · PubMed · Cited by 2,549
The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy
Thomlinson, R. H., & Gray, L. H. (1955) · British Journal of Cancer · doi:10.1038/bjc.1955.55 · Cited by 2,219
(1977) · PubMed · Cited by 1,801
Rapid Clearance of Fetal DNA from Maternal Plasma
Lo, Y. M. D., Zhang, J., Leung, T. N., Lau, T. K., Chang, A. M. Z., & Hjelm, N. M. (1999) · The American Journal of Human Genetics · doi:10.1086/302205 · Cited by 1,157
Systemic Therapy for Colorectal Cancer
Meyerhardt, J. A., & Mayer, R. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra040958 · Cited by 1,043
Systemic Therapy for Colorectal Cancer
Varghese, A. M. (2019) · DeckerMed CGSO Case-Based Reviews · doi:10.2310/cgso.16189 · Cited by 883
Identification of p53 Gene Mutations in Bladder Cancers and Urine Samples
Sidransky, D., Von Eschenbach, A., Tsai, Y. C., Jones, P., Summerhayes, I., Marshall, F., Paul, M., Green, P., Hamilton, S. R., Frost, P., et al. (1991) · Science · doi:10.1126/science.2024123 · Cited by 875
Self-citationDressman, D., Yan, H., Traverso, G., Kinzler, K. W., & Vogelstein, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1133470100 · Cited by 844
Self-citation
Research works printed but not linked: 4
- 10.1002/(SICI)1096-9896(200001)190:1<6::AID-PATH486>3.0.CO;2-M · doi:10.1002/(sici)1096-9896(200001)190:1<6::aid-path486>3.0.co;2-m
- Leon, S. A., Shapiro, B., Sklaroff, D. M. & Yaros, M. J. (1977) Cancer Res. 37, 646-650.837366
- Sozzi, G., Conte, D., Mariani, L., Lo Vullo, S., Roz, L., Lombardo, C., Pierotti, M. A. & Tavecchio, L. (2001) Cancer Res. 61, 4675-4678.11406535
- Jahr, S., Hentze, H., Englisch, S., Hardt, D., Fackelmayer, F. O., Hesch, R. D. & Knippers, R. (2001) Cancer Res. 61, 1659-1665.11245480
Cited by
Items 101–200 of 1,000
Chmielecki, J., Mok, T., Wu, Y.-L., Han, J.-Y., Ahn, M.-J., Ramalingam, S. S., John, T., Okamoto, I., Yang, J. C.-H., Shepherd, F. A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-35962-x · Cited by 200
Detection of PIK3CA mutations in circulating free DNA in patients with breast cancer
Board, R. E., Wardley, A. M., Dixon, J. M., Armstrong, A. C., Howell, S., Renshaw, L., Donald, E., Greystoke, A., Ranson, M., Hughes, A., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0747-9 · Cited by 201
Current and Emerging Applications of Droplet Digital PCR in Oncology
Olmedillas-López, S., García-Arranz, M., & García-Olmo, D. (2017) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-017-0278-8 · Cited by 201
Miniaturizing chemistry and biology in microdroplets
Kelly, B. T., Baret, J.-C., Taly, V., & Griffiths, A. D. (2007) · Chemical Communications · doi:10.1039/b616252e · Cited by 197
McBride, D. J., Orpana, A. K., Sotiriou, C., Joensuu, H., Stephens, P. J., Mudie, L. J., Hämäläinen, E., Stebbings, L. A., Andersson, L. C., Flanagan, A. M., et al. (2010) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20815 · Cited by 196
Performance of Streck cfDNA Blood Collection Tubes for Liquid Biopsy Testing
Medina Diaz, I., Nocon, A., Mehnert, D. H., Fredebohm, J., Diehl, F., & Holtrup, F. (2016) · PLOS ONE · doi:10.1371/journal.pone.0166354 · Cited by 192
Self-citationCirculating tumor DNA in advanced solid tumors: Clinical relevance and future directions
Cheng, M. L., Pectasides, E., Hanna, G. J., Parsons, H. A., Choudhury, A. D., & Oxnard, G. R. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21650 · Cited by 193
Detection and Monitoring of Cell‐Free DNA in Blood of Patients with Colorectal Cancer
Schwarzenbach, H., Stoehlmacher, J., Pantel, K., & Goekkurt, E. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.025 · Cited by 193
Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA)
Chin, R.-I., Chen, K., Usmani, A., Chua, C., Harris, P. K., Binkley, M. S., Azad, T. D., Dudley, J. C., & Chaudhuri, A. A. (2019) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-019-00390-5 · Cited by 191
Sánchez-Herrero, E., Serna-Blasco, R., Robado de Lope, L., González-Rumayor, V., Romero, A., & Provencio, M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.943253 · Cited by 184
Clonal Hematopoiesis in Liquid Biopsy: From Biological Noise to Valuable Clinical Implications
Chan, H. T., Chin, Y. M., Nakamura, Y., & Low, S.-K. (2020) · Cancers · doi:10.3390/cancers12082277 · Cited by 183
“cfDNA circulates in the blood as nucleosomes with a model fragment length of 167 bps [15,16].”
BackgroundVlassov, V. V., Laktionov, P. P., & Rykova, E. Y. (2007) · BioEssays · doi:10.1002/bies.20604 · Cited by 182
Drug-tolerant persister cells in cancer: the cutting edges and future directions
Pu, Y., Li, L., Peng, H., Liu, L., Heymann, D., Robert, C., Vallette, F., & Shen, S. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00815-5 · Cited by 175
The Effect of Preservative and Temperature on the Analysis of Circulating Tumor DNA
Parpart-Li, S., Bartlett, B., Popoli, M., Adleff, V., Tucker, L., Steinberg, R., Georgiadis, A., Phallen, J., Brahmer, J., Azad, N., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1691 · Cited by 180
Self-citationDetection of Aneuploidy with Digital Polymerase Chain Reaction
Fan, H. C., & Quake, S. R. (2007) · Analytical Chemistry · doi:10.1021/ac0709394 · Cited by 179
Karlovich, C., Goldman, J. W., Sun, J.-M., Mann, E., Sequist, L. V., Konopa, K., Wen, W., Angenendt, P., Horn, L., Spigel, D., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1260 · Cited by 179
“The principles and details of BEAMing (Symex Inostics GmbH) havebeendescribedpreviously (23).”
BackgroundMethodDigital PCR analysis of circulating nucleic acids
Hudecova, I. (2015) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2015.03.015 · Cited by 178
Mohan, S., Heitzer, E., Ulz, P., Lafer, I., Lax, S., Auer, M., Pichler, M., Gerger, A., Eisner, F., Hoefler, G., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004271 · Cited by 177
Methylated circulating tumor DNA in blood: power in cancer prognosis and response
Warton, K., Mahon, K. L., & Samimi, G. (2016) · Endocrine-Related Cancer · doi:10.1530/erc-15-0369 · Cited by 176
Colorectal cancer: molecular features and clinical opportunities.
Worthley, D. L., & Leggett, B. (2010) · Europe PMC (PubMed Central) · Cited by 277
Establishment of tumor‐specific copy number alterations from plasma DNA of patients with cancer
Heitzer, E., Auer, M., Hoffmann, E. M., Pichler, M., Gasch, C., Ulz, P., Lax, S., Waldispuehl‐Geigl, J., Mauermann, O., Mohan, S., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28030 · Cited by 175
Lianidou, E., & Pantel, K. (2019) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.22695 · Cited by 171
Jia, S., Zhang, R., Li, Z., & Li, J. (2017) · Oncotarget · doi:10.18632/oncotarget.17184 · Cited by 171
Jeannot, E., Becette, V., Campitelli, M., Calméjane, M., Lappartient, E., Ruff, E., Saada, S., Holmes, A., Bellet, D., & Sastre‐Garau, X. (2016) · The Journal of Pathology: Clinical Research · doi:10.1002/cjp2.47 · Cited by 169
Microfluidic technologies for circulating tumor cell isolation
Cho, H., Kim, J., Song, H., Sohn, K. Y., Jeon, M., & Han, K.-H. (2018) · The Analyst · doi:10.1039/c7an01979c · Cited by 167
Mattox, A. K., Douville, C., Wang, Y., Popoli, M., Ptak, J., Silliman, N., Dobbyn, L., Schaefer, J., Lu, S., Pearlman, A. H., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1252 · Cited by 165
Self-citationThe Stool DNA Test Is More Accurate Than the Plasma Septin 9 Test in Detecting Colorectal Neoplasia
Ahlquist, D. A., Taylor, W. R., Mahoney, D. W., Zou, H., Domanico, M., Thibodeau, S. N., Boardman, L. A., Berger, B. M., & Lidgard, G. P. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.10.008 · Cited by 166
Narayan, A., Carriero, N. J., Gettinger, S. N., Kluytenaar, J., Kozak, K. R., Yock, T. I., Muscato, N. E., Ugarelli, P., Decker, R. H., & Patel, A. A. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4037 · Cited by 165
“3 INTRODUCTION The release of cell-free DNA into the bloodstream from dying tumor cells has been well-documented in patients with various types of cancer(1-4).”
BackgroundSerial Assessment of Human Tumor Burdens in Mice by the Analysis of Circulating DNA
Rago, C., Huso, D. L., Diehl, F., Karim, B., Liu, G., Papadopoulos, N., Samuels, Y., Velculescu, V. E., Vogelstein, B., Kinzler, K. W., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0605 · Cited by 162
Self-citationSerum DNA can define tumor-specific genetic and epigenetic markers in gliomas of various grades
Lavon, I., Refael, M., Zelikovitch, B., Shalom, E., & Siegal, T. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop041 · Cited by 163
Padinharayil, H., Varghese, J., John, M. C., Rajanikant, G. K., Wilson, C. M., Al-Yozbaki, M., Renu, K., Dewanjee, S., Sanyal, R., Dey, A., et al. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2022.07.023 · Cited by 159
van Dessel, L. F., Beije, N., Helmijr, J. C. A., Vitale, S. R., Kraan, J., Look, M. P., de Wit, R., Sleijfer, S., Jansen, M. P. H. M., Martens, J. W. M., et al. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12037 · Cited by 162
Potential clinical utility of liquid biopsies in ovarian cancer
Zhu, J. W., Charkhchi, P., & Akbari, M. R. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01588-8 · Cited by 158
Circulating Cell-Free DNA from Colorectal Cancer Patients May Reveal High KRAS or BRAF Mutation Load
Mouliere, F., El Messaoudi, S., Gongora, C., Guedj, A.-S., Robert, B., Del Rio, M., Molina, F., Lamy, P.-J., Lopez-Crapez, E., Mathonnet, M., et al. (2013) · Translational Oncology · doi:10.1593/tlo.12445 · Cited by 159
Molecular biomarkers for lung adenocarcinoma
Calvayrac, O., Pradines, A., Pons, E., Mazières, J., & Guibert, N. (2017) · European Respiratory Journal · doi:10.1183/13993003.01734-2016 · Cited by 158
Circulating cell-free DNA for cancer early detection
Gao, Q., Zeng, Q., Wang, Z., Li, C., Xu, Y., Cui, P., Xin, Z., Lu, H., Wang, G., Cai, S., et al. (2022) · The Innovation · doi:10.1016/j.xinn.2022.100259 · Cited by 200
Simulation-guided DNA probe design for consistently ultraspecific hybridization
Wang, J. S., & Zhang, D. Y. (2015) · Nature Chemistry · doi:10.1038/nchem.2266 · Cited by 162
Laurent-Puig, P., Pekin, D., Normand, C., Kotsopoulos, S. K., Nizard, P., Perez-Toralla, K., Rowell, R., Olson, J., Srinivasan, P., Le Corre, D., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0983 · Cited by 157
Argonaute integrated single-tube PCR system enables supersensitive detection of rare mutations
Liu, Q., Guo, X., Xun, G., Li, Z., Chong, Y., Yang, L., Wang, H., Zhang, F., Luo, S., Cui, L., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab274 · Cited by 155
Sherwood, J. L., Corcoran, C., Brown, H., Sharpe, A. D., Musilova, M., & Kohlmann, A. (2016) · PLOS ONE · doi:10.1371/journal.pone.0150197 · Cited by 151
Kowalik, A., Kowalewska, M., & Góźdź, S. S. (2017) · Translational research · doi:10.1016/j.trsl.2017.04.002 · Cited by 165
Normanno, N., Cervantes, A., Ciardiello, F., De Luca, A., & Pinto, C. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.07.007 · Cited by 148
Overcoming implementation challenges of personalized cancer therapy
Meric‐Bernstam, F., & Mills, G. B. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.127 · Cited by 173
The role of companion diagnostics in the development and use of mutation-targeted cancer therapies
Papadopoulos, N., Kinzler, K. W., & Vogelstein, B. (2006) · Nature Biotechnology · doi:10.1038/nbt1234 · Cited by 161
Self-citationSingle-Molecule DNA Amplification and Analysis Using Microfluidics
Zhang, C., & Xing, D. (2010) · Chemical Reviews · doi:10.1021/cr900081z · Cited by 155
Non-invasive prenatal diagnosis by single molecule counting technologies
Chiu, R. W. K., Cantor, C. R., & Lo, Y. M. D. (2009) · Trends in Genetics · doi:10.1016/j.tig.2009.05.004 · Cited by 147
Szpechciński, A., Chorostowska‐Wynimko, J., Struniawski, R., Kupis, W. R., Rudziński, P., Langfort, R., Puścińska, E., Bieleń, P., Śliwiński, P., & Orlowski, T. M. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.225 · Cited by 162
Aghabozorgi, A. S., Bahreyni, A., Soleimani, A., Bahrami, A., Khazaei, M., Ferns, G. A., Avan, A., & Hassanian, S. M. (2019) · Biochimie · doi:10.1016/j.biochi.2018.11.003 · Cited by 144
Nanoplasmonic biosensor: Detection and amplification of dual bio-signatures of circulating tumor DNA
Anh, N. T. V., & Sim, S. J. (2014) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2014.09.003 · Cited by 143
Radpour, R., Barekati, Z., Kohler, C., Lv, Q., Bürki, N., Diesch, C., Bitzer, J., Zheng, H. Y., Schmid, S. M., & Zhong, X. Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016080 · Cited by 153
Strategies for the successful implementation of plasma-based NSCLC genotyping in clinical practice
Aggarwal, C., Rolfo, C. D., Oxnard, G. R., Gray, J. E., Sholl, L. M., & Gandara, D. R. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0423-x · Cited by 155
The dynamic range of circulating tumor DNA in metastatic breast cancer
Heidary, M., Auer, M., Ulz, P., Heitzer, E., Petru, E., Gasch, C., Riethdorf, S., Mauermann, O., Lafer, I., Pristauz, G., et al. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0421-y · Cited by 140
Cell-free circulating tumor DNA in cancer
Qin, Z., Ljubimov, V. A., Zhou, C., Tong, Y., & Liang, J. (2016) · 癌症:英文版 · doi:10.1186/s40880-016-0092-4 · Cited by 152
Normanno, N., Denis, M. G., Thress, K. S., Ratcliffe, M., & Reck, M. (2017) · Oncotarget · doi:10.18632/oncotarget.13915 · Cited by 135
Lapin, M., Oltedal, S., Tjensvoll, K., Buhl, T., Smaaland, R., Garresori, H., Javle, M. M., Glenjen, N. I., Abelseth, B. K., Gilje, B., et al. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1677-2 · Cited by 157
Overview of DNA Sequencing Strategies
Shendure, J., Porreca, G. J., Church, G. M., Gardner, A. F., Hendrickson, C. L., Kieleczawa, J., & Slatko, B. E. (2011) · Current Protocols in Molecular Biology · doi:10.1002/0471142727.mb0701s96 · Cited by 152
Mathai, R. A., Vidya, R. V. S., Reddy, B. S., Thomas, L., Udupa, K., Kolesar, J., & Rao, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8030373 · Cited by 150
Hashimoto, M., Barany, F., & Soper, S. A. (2006) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2006.01.014 · Cited by 132
Molecular Detection of Colorectal Neoplasia
Ahlquist, D. A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.055 · Cited by 139
Liquid biopsy for lung cancer early detection
Santarpía, M., Liguori, A., D’Aveni, A., Karachaliou, N., González‐Cao, M., Daffinà, M. G., Lazzari, C., Altavilla, G., & Rosell, R. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.03.81 · Cited by 146
Liquid biopsy for cancer screening, patient stratification and monitoring
Brock, G., Castellanos-Rizaldos, E., Hu, L., Coticchia, C. M., & Skog, J. (2018) · Translational Cancer Research · doi:10.21037/4546 · Cited by 155
Korshunova, Y. O., Maloney, R. K., Lakey, N. D., Citek, R. W., Bacher, B., Budiman, A., Ordway, J. M., McCombie, W. R., Leon, J., Jeddeloh, J. A., et al. (2007) · Genome Research · doi:10.1101/gr.6883307 · Cited by 138
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas
Hohaus, S., Giachelia, M., Massini, G., Mansueto, G., Vannata, B., Bozzoli, V., Criscuolo, M., D’Alò, F., Martini, M., Larocca, L. M., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp006 · Cited by 137
Circulating tumor cells and DNA as liquid biopsies
Heitzer, E., Auer, M., Ulz, P., Geigl, J. B., & Speicher, M. R. (2013) · Genome Medicine · doi:10.1186/gm477 · Cited by 143
Using circulating cell-free DNA to monitor personalized cancer therapy
Oellerich, M., Schütz, E., Beck, J., Kanzow, P., Plowman, P. N., Weiss, G. J., & Walson, P. D. (2017) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2017.1299683 · Cited by 140
Monotherapy Administration of Sorafenib in Patients With Non–Small Cell Lung Cancer (MISSION) Trial
Paz-Ares, L. G., Hirsh, V., Zhang, L., de Marinis, F., Yang, J. C., Wakelee, H. A., Seto, T., Wu, Y.-L. L. C., Novello, S., Juhász, É., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000693 · Cited by 129
Zheng, Y. W. L., Chan, K. C. A., Sun, H., Jiang, P., Su, X., Chen, E. Z., Lun, F. M. F., Hung, E. C. W., Lee, V., Wong, J., et al. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2011.169318 · Cited by 131
Circulating Free DNA as Biomarker and Source for Mutation Detection in Metastatic Colorectal Cancer
Spindler, K.-L. G., Pallisgaard, N., Andersen, R. F., Brandslund, I., & Jakobsen, A. K. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0108247 · Cited by 124
Liquid Biopsy in Clinical Management of Breast, Lung, and Colorectal Cancer
Hench, I. B., Hench, J., & Tolnay, M. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00009 · Cited by 128
Circulating tumour markers can define patients with normal colons, benign polyps, and cancers
Mead, R. J., Duku, M., Bhandari, P., & Cree, I. A. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.230 · Cited by 135
Cao, J., Shi, X., Gurav, D. D., Huang, L., Su, H., Li, K., Niu, J., Zhang, M., Wang, Q., Jiang, M., et al. (2020) · Advanced Materials · doi:10.1002/adma.202000906 · Cited by 127
Circulating DNA fragmentomics and cancer screening
Thierry, A. R. (2023) · Cell Genomics · doi:10.1016/j.xgen.2022.100242 · Cited by 140
Chen, Y.-H., Hancock, B. A., Solzak, J. P., Brinza, D., Scafe, C., Miller, K. D., & Radovich, M. (2017) · npj Breast Cancer · doi:10.1038/s41523-017-0028-4 · Cited by 121
Circulating Nucleic Acids in Plasma and Serum: Recent Developments
Gahan, P. B., & Swaminathan, R. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1448.050 · Cited by 121
The potential of circulating cell-free RNA as a cancer biomarker: challenges and opportunities
Zaporozhchenko, I. A., Ponomaryova, A. A., RYKOVA, E. Y., & Laktionov, P. P. (2018) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1425143 · Cited by 131
Belic, J., Koch, M., Ulz, P., Auer, M., Gerhalter, T., Mohan, S., Fischereder, K., Petru, E., Bauernhofer, T., Geigl, J. B., et al. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.234286 · Cited by 119
Circulating nucleic acids as biomarkers in breast cancer
Schwarzenbach, H. (2013) · Breast Cancer Research · doi:10.1186/bcr3446 · Cited by 137
Going with the Flow: From Circulating Tumor Cells to DNA
Bidard, F., Weigelt, B., & Reis-Filho, J. S. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006305 · Cited by 128
Pinzani, P., D’Argenio, V., Re, M. D., Pellegrini, C., Cucchiara, F., Salvianti, F., & Galbiati, S. (2021) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-1685 · Cited by 136
Blood biomarkers for differential diagnosis and early detection of pancreatic cancer
Al-Shaheri, F. N., Alhamdani, M. S. S., Bauer, A. S., Giese, N. A., Büchler, M. W., Hackert, T., & Hoheisel, J. D. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2021.102193 · Cited by 132
Espósito, A., Bardelli, A., Criscitiello, C., Colombo, N., Gelao, L., Fumagalli, L. A. M., Minchella, I., Locatelli, M., Goldhirsch, A., & Curigliano, G. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.10.003 · Cited by 125
The dawn of the liquid biopsy in the fight against cancer
Domínguez-Vigil, I. G., Moreno-Martínez, A. K., Wang, J. Y., Roehrl, M. H. A., & Barrera-Saldaña, H. A. (2017) · Oncotarget · doi:10.18632/oncotarget.23131 · Cited by 137
Predicting Radiotherapy Responses and Treatment Outcomes Through Analysis of Circulating Tumor DNA
Chaudhuri, A. A., Binkley, M. S., Osmundson, E. C., Alizadeh, A. A., & Diehn, M. (2015) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2015.05.001 · Cited by 113
Liquid Biopsy, ctDNA Diagnosis through NGS
Chen, L., Liu, X., Zheng, B., Ke, R., & Tzeng, C. (2021) · Life · doi:10.3390/life11090890 · Cited by 132
Cell-Free DNA Fragmentomics in Liquid Biopsy
Ding, S. C., & Lo, Y. M. D. (2022) · Diagnostics · doi:10.3390/diagnostics12040978 · Cited by 126
Detecting biomarkers with microdroplet technology
Taly, V., Pekin, D., Abed, A. I. E., & Laurent‐Puig, P. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.05.001 · Cited by 125
Duffy, M. J., Walsh, S. M., McDermott, E. W. M., & Crown, J. P. (2015) · Advances in clinical chemistry · doi:10.1016/bs.acc.2015.05.001 · Cited by 136
Liquid biopsy for therapy monitoring in early-stage non-small cell lung cancer
Nagasaka, M., Uddin, M. H., Hallak, M. N. A., Rahman, S. B., Balasubramanian, S. K., Sukari, A. W., & Azmi, A. S. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01371-1 · Cited by 124
Perkins, G., Lu, H., Garlan, F., & Taly, V. (2016) · Advances in clinical chemistry · doi:10.1016/bs.acc.2016.10.001 · Cited by 135
NanoVelcro rare-cell assays for detection and characterization of circulating tumor cells
Jan, Y. J., Chen, J., Zhu, Y., Lu, Y., Chen, S. H., Chung, H., Smalley, M. D., Huang, Y.-W., Dong, J., Chen, L.-C., et al. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.03.006 · Cited by 119
Mutation Detection by Real-Time PCR: A Simple, Robust and Highly Selective Method
Morlan, J., Baker, J., & Sinicropi, D. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004584 · Cited by 113
Liao, W., Yang, H., Xu, H., Wang, Y., Ge, P., Ren, J., Xu, W., Lu, X., Sang, X., Zhong, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9629 · Cited by 116
Saliva-Exosomics in Cancer: Molecular Characterization of Cancer-Derived Exosomes in Saliva
NONAKA, T., & Wong, D. T. (2017) · The Enzymes · doi:10.1016/bs.enz.2017.08.002 · Cited by 131
Circulating cell-free DNA for non-invasive cancer management
Stewart, C. M., & Tsui, D. W. Y. (2018) · Cancer Genetics · doi:10.1016/j.cancergen.2018.02.005 · Cited by 114
Clinical Circulating Tumor DNA Testing for Precision Oncology
Kim, H., & Park, K. U. (2023) · Cancer Research and Treatment · doi:10.4143/crt.2022.1026 · Cited by 135
Quantification of Free Circulating Tumor DNA as a Diagnostic Marker for Breast Cancer
Catarino, R., Ferreira, M. M., Rodrigues, H., Coelho, A., Nogal, A., Sousa, A., & Medeiros, R. (2008) · DNA and Cell Biology · doi:10.1089/dna.2008.0744 · Cited by 111
Butler, T. M., Johnson-Camacho, K., Peto, M., Wang, N. J., Macey, T. A., Korkola, J. E., Koppie, T. M., Corless, C. L., Gray, J. W., & Spellman, P. T. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136407 · Cited by 118
Benešová, L., Belšánová, B., Suchánek, Š., Kopeckova, M., Mináriková, P., Lipská, L., Levý, M., Visokai, V., Zavoral, M., & Minárik, M. (2012) · Analytical Biochemistry · doi:10.1016/j.ab.2012.06.018 · Cited by 116
Detection of IDH1 mutation in the plasma of patients with glioma
Boisselier, B., Pérez‐Larraya, J. G., Rossetto, M., Labussière, M., Ciccarino, P., Marie, Y., Delattre, J., & Sanson, M. (2012) · Neurology · doi:10.1212/wnl.0b013e31826e9b0a · Cited by 120
A clinician’s handbook for using ctDNA throughout the patient journey
Hasenleithner, S. O., & Speicher, M. R. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01551-7 · Cited by 116
Metadata
- Authors
- Diehl, F., Li, M., Dressman, D., He, Y., Shen, D., Szabo, S., Diaz, L. A., Goodman, S. N., David, K. A., Juhl, H., Kinzler, K. W., & Vogelstein, B.
- Affiliations
- Howard Hughes Medical Institute (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2005-10-28
- Volume
- 102
- Issue
- 45
- Pages
- 16368-16373
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1283450
- OpenAlex
- W2015438948
- Cited by
- 1,188
- References
- 39
- Citations by year
- 2026: 17 · 2025: 34 · 2024: 44 · 2023: 75 · 2022: 91 · 2021: 76 · 2020: 88 · 2019: 111 · 2018: 97 · 2017: 93 · 2016: 90 · 2015: 66 · 2014: 61 · 2013: 46 · 2012: 44
- FWCI
- 8.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (CA62924, CA43460, CA57345)
- National Cancer Institute (CA 57345, CA43460, R37CA043460, R01CA057345, P50CA062924, R37CA057345, CA 62924)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Keywords
- circulating tumor DNA, colorectal cancer, APC mutation, liquid biopsy, early cancer detection
- MeSH terms
- Adult, Aged, Aged, 80 and over, DNA, Neoplasm, Female, Humans, Male, Middle Aged, Mutation, Sensitivity and Specificity, Colorectal Neoplasms, Genes, APC
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.